Oscillation and Lung Expansion Therapy in Patients With COVID-19

NAUnknownINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

April 30, 2022

Study Completion Date

June 30, 2022

Conditions
COVID-19Oscillation and Lung Expansion
Interventions
DEVICE

MetaNeb® System

The intervention device use in this study is The MetaNeb® System (Hill-Rom; St. Paul, MN). It is an FDA 510k cleared device (k124032), powered by compressed gas, that delivers oscillation and lung expansion (OLE) therapy using both continuous high-frequency oscillation (CHFO) and continuous positive expiratory pressure (CPEP). The device also provides supplemental oxygen when used with compressed oxygen and can deliver aerosol therapy during CPEP and/or CHFO. The therapy is indicated for mobilization of secretions, lung expansion therapy and the treatment and prevention of pulmonary atelectasis. The device also provides supplemental oxygen when used with compressed oxygen.

Trial Locations (2)

30322

RECRUITING

Emory University, Atlanta

60208

RECRUITING

Northwestern University, Evanston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Emory University

OTHER

collaborator

Northwestern University

OTHER

lead

Hill-Rom

INDUSTRY